Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin vs Hetastarch in Acute Lung Injury (CEASE)
NCT00796419Phase 3Terminated
- Sponsor
- Emory University
- Start
- Jan 2009
- Primary completion
- Nov 2015
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of albumin (human), hetastarch in acute lung injury (ALI), acute respiratory distress syndrome (ARDS), sponsored by Emory University. Started Jan 2009; status: terminated.
02
Drugs
albumin (human)hetastarch
03
Conditions
acute lung injury (ALI)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT00796419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796419.